Active therapy for chronic low back pain: part 2. Effects on paraspinal muscle cross-sectional area, fiber type size, and distribution.
about
Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level.The value of physical performance tests for predicting therapy outcome in patients with subacute low back pain: a prospective cohort study.The effect of exercise training on lower trunk muscle morphology.Paraspinal muscles density: a marker for degenerative lumbar spinal stenosis?A non-randomized clinical control trial of Harrison mirror image methods for correcting trunk list (lateral translations of the thoracic cage) in patients with chronic low back pain.Fat in the lumbar multifidus muscles - predictive value and change following disc prosthesis surgery and multidisciplinary rehabilitation in patients with chronic low back pain and degenerative disc: 2-year follow-up of a randomized trial.An investigation into the use of MR imaging to determine the functional cross sectional area of lumbar paraspinal musclesThe association of physical deconditioning and chronic low back pain: a hypothesis-oriented systematic review.Analysis of Relationship between Paraspinal Muscle Fatty Degeneration and Cervical Spine Motion Using Kinetic Magnetic Resonance Imaging.Myosteatosis and myofibrosis: relationship with aging, inflammation and insulin resistance.Quantification of intermuscular adipose tissue in the erector spinae muscle by MRI: agreement with histological evaluation.Comparison of three active therapies for chronic low back pain: results of a randomized clinical trial with one-year follow-up.Lumbar multifidus muscle degenerates in individuals with chronic degenerative lumbar spine pathology.The Association between Imaging Parameters of the Paraspinal Muscles, Spinal Degeneration, and Low Back Pain.The early changes in trunk muscle strength and disability following lumbar spine fusion.Contribution of Lumbar Spine Pathology and Age to Paraspinal Muscle Size and Fatty Infiltration.Reliability and Validity of a New Method for Isometric Back Extensor Strength Evaluation Using A Hand-Held Dynamometer.The use of electromyography and magnetic resonance imaging to evaluate a core strengthening exercise programme.Cross-sectional area of human trunk paraspinal muscles before and after posterior lumbar surgery using magnetic resonance imaging.Assessment of Paraspinal Muscle Atrophy Percentage after Minimally Invasive Transforaminal Lumbar Interbody Fusion and Unilateral Instrumentation Using a Novel Contralateral Intact Muscle-Controlled Model.
P2860
Q33732810-D04B4EFB-FB1D-40E3-BB5D-982884F32F99Q33972975-90449B9D-6F7E-42EB-A820-2A0DEC7A2BD3Q35205784-0D0CFD06-AC60-4002-99A9-DFC685C64015Q36159803-C9A507AF-641E-45E0-9494-B23AF8906F2BQ36333951-3023EECF-AAA9-4119-969A-43F8303E674CQ36334596-FE62DB06-B0AC-48AB-9CBA-B2B59485D886Q36372594-7DB24ED3-690F-4E59-A9FB-409580AEE0D3Q36523543-380A1345-27BD-455E-A21F-F8C71B47DE09Q37395401-3FA17C35-8886-459C-BC26-E61736FA0CDAQ37612828-2B641051-B8FE-4E01-952F-F962FCF6908EQ37612831-FD971119-9C4B-4F5C-AF46-86A031735131Q38470852-9104F947-032F-4749-AC24-E0FB8F3FE57FQ38798710-AE451BC4-DB96-4AAA-BF77-7111B247ABE9Q39242093-7491E389-6771-44E5-B656-B1532D7FDC31Q39246752-3111B56F-7C13-429D-BC9E-FB01DADDFD3DQ39496117-F84CB922-3ACF-405D-ADD1-9B965ECCEF33Q45351442-4CEDA17C-38B4-4E0F-94E5-D2EF08D3123AQ50071595-2D22042A-8B32-40C0-B884-F517EFE69ABCQ53508850-AC41941A-3B27-4546-A5A3-699A4B72D3A0Q53827441-D9CEE934-4222-42AB-BF91-3305D3702945
P2860
Active therapy for chronic low back pain: part 2. Effects on paraspinal muscle cross-sectional area, fiber type size, and distribution.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Active therapy for chronic low ...... r type size, and distribution.
@en
Active therapy for chronic low ...... r type size, and distribution.
@nl
type
label
Active therapy for chronic low ...... r type size, and distribution.
@en
Active therapy for chronic low ...... r type size, and distribution.
@nl
prefLabel
Active therapy for chronic low ...... r type size, and distribution.
@en
Active therapy for chronic low ...... r type size, and distribution.
@nl
P2093
P1433
P1476
Active therapy for chronic low ...... er type size, and distribution
@en
P2093
P304
P356
10.1097/00007632-200104150-00014
P407
P577
2001-04-01T00:00:00Z